ClinicalTrials.gov
ClinicalTrials.gov Menu

42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01381094
Recruitment Status : Completed
First Posted : June 27, 2011
Last Update Posted : May 2, 2016
Sponsor:
Information provided by (Responsible Party):
Akebia Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2012
  Actual Study Completion Date : March 2012
  Certification/Extension First Submitted : October 3, 2012